Gastroretentive dosage forms for minocycline
US9561241B1 · kind B1 · utility
1Cited by
82References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 28, 2012 |
| Grant date | Feb 7, 2017 |
| Priority date | — |
| Expiry date | Jun 28, 2032 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K9/2054
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure relates to dosage forms and methods that enhance the absorption of minocycline in the gastrointestinal tract and thereby enhance bioavailability of the minocycline, and further provides methods of using these dosage forms for the treatment of conditions such as acne.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.